Arcus Biosciences (RCUS) Operating Expenses (2017 - 2026)
Arcus Biosciences (RCUS) posted quarterly Operating Expenses of $151.0 million for Q1 2026, up 0.67% year-over-year from $150.0 million in Q1 2025, and up 2.72% quarter-over-quarter from $147.0 million in Q4 2025.
Arcus Biosciences (RCUS) Operating Expenses (2017 - 2026) Analysis & Trends
Arcus Biosciences' Operating Expenses history runs 10 years deep, the most recent figure standing at $151.0 million for Q1 2026.
- In Q1 2026, Operating Expenses rose 0.67% year-over-year to $151.0 million; the TTM figure through Mar 2026 stood at $634.0 million (up 9.88% YoY), while the FY2025 annual figure was $633.0 million, up 7.65% from the prior year.
- Operating Expenses for Q1 2026 stood at $151.0 million, up from $147.0 million in the prior quarter.
- The five-year high for Operating Expenses was $168.0 million in Q2 2025, with the low at $85.0 million in Q1 2022.
- The 5-year median for Operating Expenses is $129.0 million (2024), against an average of $130.6 million.
- The sharpest annual moves came in 2022 and 2025: Operating Expenses surged 46.74% in 2022, then declined 6.83% in 2025.
- Arcus Biosciences' Operating Expenses stood at $108.0 million in 2022, then gained by 12.96% to $122.0 million in 2023, then climbed by 5.74% to $129.0 million in 2024, then grew by 13.95% to $147.0 million in 2025, then gained by 2.72% to $151.0 million in 2026.
- Business Quant data shows RCUS's Operating Expenses at $151.0 million in Q1 2026, $147.0 million in Q4 2025, and $168.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Arcus Biosciences | 3.74 Bn | 3.04 Bn | - | 137.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 137.00 Mn |
| Mar 31, 2026 | 151.00 Mn |
| Dec 31, 2025 | 147.00 Mn |
| Sep 30, 2025 | 168.00 Mn |
| Jun 30, 2025 | 168.00 Mn |
| Mar 31, 2025 | 150.00 Mn |
| Dec 31, 2024 | 129.00 Mn |
| Sep 30, 2024 | 153.00 Mn |
| Jun 30, 2024 | 145.00 Mn |
| Mar 31, 2024 | 161.00 Mn |
| Dec 31, 2023 | 122.00 Mn |
| Sep 30, 2023 | 112.00 Mn |
| Jun 30, 2023 | 112.00 Mn |
| Mar 31, 2023 | 111.00 Mn |
| Dec 31, 2022 | 108.00 Mn |
| Sep 30, 2022 | 103.00 Mn |
| Jun 30, 2022 | 96.00 Mn |
| Mar 31, 2022 | 85.00 Mn |
| Dec 31, 2021 | 73.60 Mn |
| Sep 30, 2021 | 87.60 Mn |